Plain-English translation of NCT07652762 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
China
Safety & dosing
Sponsor
Capital Medical University
Enrollment target
~24 participants
Started
August 2026
Primary completion
August 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Research Secretary
Beijing Sanbo Brain Hospital, Capital Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.